GGrantIndex
Sort

21,453 grants matching tuberculosis

Clinical and biologic risk factors for post-tuberculosis lung disease (PTLD) in people with and without HIV

$152,064
Jerry S. Zifodya · Tulane University Of Louisiana · K23 · FY2025 · HL

Radio Frequency Probe Development

$152,059
William W Brey · Florida State University · P01 · FY2011 · AI

Molecular Diagnostic Tools for Patient Oriented Field Studies in Infectious Disea

$152,048
Eric R Houpt · University Of Virginia · K24 · FY2016 · AI

Molecular Diagnostic Tools for Patient Oriented Field Studies in Infectious Disea

$152,048
Eric R Houpt · University Of Virginia · K24 · FY2013 · AI

Molecular Diagnostic Tools for Patient Oriented Field Studies in Infectious Disea

$152,048
Eric R Houpt · University Of Virginia · K24 · FY2014 · AI

Molecular Diagnostic Tools for Patient Oriented Field Studies in Infectious Disea

$152,048
Eric R Houpt · University Of Virginia · K24 · FY2017 · AI

Molecular Diagnostic Tools for Patient Oriented Field Studies in Infectious Disea

$152,048
Eric R Houpt · University Of Virginia · K24 · FY2015 · AI

Therapeutic vaccine against tuberculosis

$152,000
University Of California Berkeley · R21 · FY2005 · AI

Clinical Research in Tuberculosis

$151,994
Johns Hopkins University · K24 · FY2005 · AI

Mechanisms of mosquito midgut invasion by Plasmodium ookinetes

$151,875
Marcelo Jacobs-Lorena · Johns Hopkins University · R56 · FY2014 · AI

Vaccine and Treatment Evaluation Unit at Saint Louis University

$151,855
Daniel F. Hoft · Saint Louis University · UM1 · FY2022 · AI

M TUBERCULOSIS EVASION OF IMMUNE EFFECTOR MECHANISMS

$151,841
New York University School Of Medicine · R01 · FY2002 · AI

Building Capacity for Trauma Quality Improvement: An Innovative Pilot Program in Cameroon to Address the Burden of Injury

$151,691
Catherine Juillard · University Of California Los Angeles · R21 · FY2019 · TW

Immunodiagnosis of Active Tuberculosis in HIV-infected Patients

$151,643
Adithya Cattamanchi · University Of California, San Francisco · K23 · FY2010 · HL

Inflammatory determinants of disease severity and treatment outcome in TB patients

$151,636
Robert John Wilkinson · University Of Cape Town · U01 · FY2019 · AI

Effects of Air Pollution on Childhood Tuberculosis in Viet Nam

$151,578
Robert J Blount · University Of Iowa · K23 · FY2018 · ES

Effects of Air Pollution on Childhood Tuberculosis in Viet Nam

$151,578
Robert J Blount · University Of California, San Francisco · K23 · FY2015 · ES

Effects of Air Pollution on Childhood Tuberculosis in Viet Nam

$151,578
Robert J Blount · University Of Iowa · K23 · FY2019 · ES

Host-Pathogen Interactions in a Failing Global lineage of MTBC:M.africanum

$151,526
Souleymane Diallo · Univ Of Sciences, Tech & Tech Of Bamako · R01 · FY2017 · AI

My Mobile Wallet: An Intervention to Support Access to Tuberculosis Care and Medication Adherence in Rural Uganda

$151,507
Angella Musiimenta · Mbarara University/Science/ Technology · R21 · FY2021 · HD

Synthetic and biological studies of understudied anti-tubercular natural products

$151,505
Ryan Murelli · Brooklyn College · SC2 · FY2013 · GM

Core--FACS

$151,453
Steven A Porcelli · Albert Einstein College Of Medicine · P01 · FY2007 · AI

Directly observed antiretroviral therapy in drug abusers

$151,442
Johns Hopkins University · K23 · FY2003 · DA

Interrogating inflammatory responses to SARS-CoV-2 infection in vivo

$151,414
Katrin Mayer-Barber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI

Immunodiagnosis of Active Tuberculosis in HIV-infected Patients

$151,410
Adithya Cattamanchi · University Of California, San Francisco · K23 · FY2009 · HL